Local Anesthetics Practice Questions

Q: Which of the following local anesthetic agents, when used with epinephrine, provides long-duration anesthesia?

0.5% Bupivacaine + Epinephrine 1:200,000. **Explanation:** The duration of action of a local anesthetic (LA) is primarily determined by its **protein binding capacity**. Agents with high protein binding remain at the receptor site in the nerve membrane for a longer period. **Why D is correct:** **Bupivacaine** is a potent, long-acting amide local anesthetic with very high protein binding (approx. 95%). While it is inherently long-acting, the addition of **Epinephrine (1:200,000)** acts as a vasoconstrictor. This reduces regional blood flow, slowing the systemic absorption of the drug and further prolonging its local analgesic effect. It typically provides anesthesia for 4–8 hours, making it the gold standard for long-duration procedures and postoperative pain management. **Why other options are incorrect:** * **A. 2% Lidocaine:** This is an intermediate-acting agent. Even with epinephrine, its duration is significantly shorter (approx. 2–3 hours) than Bupivacaine. * **B. 3% Mepivacaine:** This is an intermediate-acting agent. It lacks significant vasodilator properties (unlike lidocaine), but its protein binding is lower than bupivacaine, resulting in a shorter duration. * **C. 4% Prilocaine:** Also an intermediate-acting agent. It is metabolized to ortho-toluidine, which can cause methemoglobinemia in high doses. **High-Yield Clinical Pearls for NEET-PG:** * **Potency** is determined by **Lipid Solubility**. * **Duration of Action** is determined by **Protein Binding**. * **Onset of Action** is determined by **pKa** (Lower pKa = Faster onset). * **Bupivacaine Toxicity:** It is highly cardiotoxic (blocks sodium channels in the heart). The treatment of choice for Bupivacaine-induced systemic toxicity (LAST) is **20% Intralipid emulsion**. * **Epinephrine Contraindication:** Never use epinephrine-containing LAs in "end-artery" areas (fingers, toes, nose, penis, pinna) due to the risk of gangrene.

Q: Which local anesthetic is known for its differential blockade properties, making it a preferred choice or a differential block option?

Ropivacaine. ### Explanation **Concept of Differential Blockade** Differential blockade refers to the ability of a local anesthetic to selectively block sensory nerve fibers (pain) while sparing motor nerve fibers. This is highly desirable in obstetric analgesia (painless labor) and postoperative pain management, as it allows patients to remain mobile while being pain-free. **Why Ropivacaine is the Correct Answer** Ropivacaine, an amino-amide local anesthetic and the pure S-enantiomer of bupivacaine, is the drug of choice for differential blockade. It is less lipophilic than bupivacaine, which makes it less likely to penetrate the large, myelinated A-alpha motor fibers. Consequently, at lower concentrations (e.g., 0.2%), it provides excellent sensory analgesia with minimal motor impairment. Additionally, it has a higher threshold for cardiotoxicity compared to bupivacaine. **Analysis of Incorrect Options** * **A. Lignocaine:** Known for its rapid onset and intermediate duration. It produces a dense, non-selective block where motor and sensory fibers are affected almost simultaneously. * **C. Bupivacaine:** While it also exhibits some differential block, it is significantly less selective than ropivacaine. It carries a higher risk of cardiotoxicity (due to slow dissociation from sodium channels). * **D. Dibucaine:** An amino-ester anesthetic primarily used for its "Dibucaine Number" to test for atypical pseudocholinesterase deficiency; it is not used for differential blockade in clinical practice. **High-Yield Clinical Pearls for NEET-PG** * **Cardiotoxicity:** Ropivacaine is safer than Bupivacaine because it dissociates faster from cardiac sodium channels. * **Vasoconstriction:** Unlike most local anesthetics (which are vasodilators), Ropivacaine has inherent vasoconstrictive properties. * **S-Enantiomers:** Both Ropivacaine and Levobupivacaine are pure S-enantiomers, designed to reduce the systemic toxicity associated with the racemic mixtures.

Q: What is the maximum recommended dose of lignocaine with adrenaline in mg/kg?

7. **Explanation:** The maximum recommended dose of Lignocaine (Lidocaine) is determined by its systemic toxicity profile. The addition of **adrenaline (epinephrine)**, typically in a 1:200,000 concentration, causes local vasoconstriction. This slows the systemic absorption of the anesthetic, prolonging its duration of action and allowing for a higher safe dosage threshold. * **Correct Answer (C - 7 mg/kg):** For Lignocaine **with** adrenaline, the maximum safe dose is **7 mg/kg**. This is a high-yield value frequently tested in NEET-PG. * **Option B (5 mg/kg):** This is the maximum recommended dose for Lignocaine **plain** (without adrenaline). Exceeding this increases the risk of Local Anesthetic Systemic Toxicity (LAST). * **Option A (4 mg/kg):** This is below the standard safe limit for Lignocaine but is closer to the maximum dose for Bupivacaine (2-3 mg/kg). * **Option D (10 mg/kg):** This exceeds the safety margin for Lignocaine and would likely result in CNS or cardiovascular toxicity. **High-Yield Clinical Pearls for NEET-PG:** 1. **Absolute Max Dose:** Regardless of weight, the total dose of Lignocaine with adrenaline should generally not exceed **500 mg**. 2. **Bupivacaine Limits:** Plain = 2 mg/kg; with adrenaline = 3 mg/kg. 3. **Toxicity Sequence:** CNS symptoms (perioral numbness, metallic taste, seizures) usually precede Cardiovascular Collapse (CVC) with Lignocaine. 4. **Antidote:** Intravenous **Lipid Emulsion (20% Intralipid)** is the specific treatment for LAST.

Q: Which of the following local anesthetics should not be mixed with adrenaline?

Cocaine. **Explanation:** **1. Why Cocaine is the Correct Answer:** Cocaine is unique among local anesthetics because it possesses intrinsic **sympathomimetic activity**. It works by blocking the reuptake of norepinephrine at sympathetic nerve endings, leading to intense vasoconstriction and tachycardia. Adding adrenaline (epinephrine) to cocaine would result in a synergistic effect, causing dangerous levels of vasoconstriction, severe hypertension, and potentially fatal cardiac arrhythmias or myocardial ischemia. Therefore, it is the only local anesthetic where the addition of adrenaline is strictly contraindicated. **2. Why Other Options are Incorrect:** * **Lignocaine & Bupivacaine:** These are the most common local anesthetics used with adrenaline. Since they are vasodilators, adrenaline is added to provide local vasoconstriction, which decreases systemic absorption (reducing toxicity), prolongs the duration of action, and provides a bloodless surgical field. * **Mepivacaine:** While mepivacaine has mild intrinsic vasoconstrictive properties compared to lignocaine, it is still frequently and safely combined with adrenaline to enhance its clinical profile. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Cocaine is an ester-type anesthetic; all others in the options are amides (except cocaine). * **Ester vs. Amide:** Remember the "i" rule—Amides have two "i"s in their name (L**i**doca**i**ne, Bup**i**vaca**i**ne), while Esters have only one (Coca**i**ne, Proca**i**ne). * **Adrenaline Concentration:** The standard concentration used with local anesthetics is **1:200,000**. * **Contraindication Sites:** Never use adrenaline-containing local anesthetics in "end-artery" areas (fingers, toes, nose, ears, and penis) due to the risk of gangrene.

Q: What is the cause of the sensation of tissue tearing during the administration of local anesthesia?

Barb on the needle. ### Explanation **Correct Answer: D. Barb on the needle** The sensation of "tissue tearing" or "dragging" during the insertion or withdrawal of a needle is a classic clinical sign of a **barbed needle**. A barb is a microscopic hook at the tip of the needle, usually caused by the needle tip striking bone during a previous injection attempt or accidental contact with a hard surface. As the needle moves through the tissues, this hook catches and tears the connective tissue fibers, causing both the characteristic sensation for the clinician and significant post-operative pain or trismus for the patient. **Analysis of Incorrect Options:** * **A. Passage through a cyst:** This typically results in a "loss of resistance" or a sudden "pop" followed by ease of flow, rather than a tearing sensation. * **B. Passage through a muscle:** Muscle penetration usually offers steady, firm resistance. While it may cause discomfort, it does not produce a tactile tearing sensation unless the needle is damaged. * **C. Passage through an area of infection:** Infected tissues are often more vascular and edematous (acidic environment). Injection here is usually associated with intense burning pain due to the pH shift and increased pressure, but not a mechanical tearing sensation. **High-Yield NEET-PG Pearls:** * **Prevention:** Always discard a needle after it has touched bone or if it has been used for more than 3–4 penetrations in the same patient. * **Safety Check:** To check for a barb before injection, draw the needle backward across a sterile gauze pad; if it snags the fibers, the needle is barbed and must be replaced. * **Complication:** Using a barbed needle significantly increases the risk of **needle breakage**, a rare but serious complication in regional anesthesia.

Q: What is the maximum dose of lignocaine without adrenaline that can be administered to a patient?

4 mg/kg body weight. **Explanation:** Lignocaine (Lidocaine) is an amide-linked local anesthetic that acts by blocking voltage-gated sodium channels. The maximum safe dose is determined by the risk of **Systemic Toxicity (LAST)**, which occurs when plasma levels rise due to excessive administration or accidental intravascular injection. 1. **Why Option A is Correct:** For **plain lignocaine (without adrenaline)**, the maximum recommended dose is **3–4 mg/kg body weight**. This limit is set to prevent CNS side effects (like seizures) and cardiovascular collapse. In a standard 70 kg adult, this equates to approximately 200–280 mg. 2. **Why Option C is Incorrect:** **7 mg/kg** is the maximum dose for **lignocaine with adrenaline (1:200,000)**. Adrenaline acts as a vasoconstrictor, slowing systemic absorption, prolonging the duration of action, and reducing peak plasma levels, thereby allowing a higher dose to be administered safely. 3. **Why Options B and D are Incorrect:** These values do not correspond to standard safety guidelines for lignocaine. 5 mg/kg is sometimes cited in older texts but is generally considered less conservative than 4 mg/kg in modern practice. 9 mg/kg exceeds the safety threshold for both plain and adrenaline-combined lignocaine. **High-Yield Clinical Pearls for NEET-PG:** * **Bupivacaine:** Max dose is **2 mg/kg** (plain) and **3 mg/kg** (with adrenaline). It is significantly more cardiotoxic than lignocaine. * **Treatment of Toxicity:** Intravenous **Lipid Emulsion (20% Intralipid)** is the specific antidote for Local Anesthetic Systemic Toxicity (LAST). * **Order of Blockade:** Autonomic fibers > Pain/Temperature (A-delta & C) > Touch/Pressure > Motor. * **Metabolism:** Amides (like Lignocaine) are metabolized in the **liver** (P450 system), whereas Esters (like Procaine) are metabolized by **plasma pseudocholinesterase**.

Question 1

Which of the following local anesthetic agents, when used with epinephrine, provides long-duration anesthesia?

Accepted Answer

0.5% Bupivacaine + Epinephrine 1:200,000

Answer

2% Lidocaine HCl + Epinephrine 1:200,000

Answer

3% Mepivacaine HCl

Answer

4% Prilocaine HCl + Epinephrine 1:200,000

Question 2

Which local anesthetic is known for its differential blockade properties, making it a preferred choice or a differential block option?

Accepted Answer

Ropivacaine

Answer

Lignocaine

Answer

Bupivacaine

Answer

Dibucaine

Question 3

What is the maximum recommended dose of lignocaine with adrenaline in mg/kg?

Accepted Answer

7

Answer

4

Answer

5

Answer

10

Question 4

On the administration of local anesthetic in an area of infection, what is the predominant form of the local anesthetic?

Accepted Answer

Increased cationic form

Answer

Buffering capacity of the local anesthetic is decreased

Answer

Decreased concentration of the uncharged base

Answer

Decreased concentration of charged cations

Question 5

Which of the following local anesthetics should not be mixed with adrenaline?

Accepted Answer

Cocaine

Answer

Lignocaine

Answer

Bupivacaine

Answer

Mepivacaine

Question 6

Which of the following local anesthetics does not require the addition of adrenaline?

Accepted Answer

Cocaine

Answer

Procaine

Answer

Lignocaine

Answer

Bupivacaine

Question 7

What is the cause of the sensation of tissue tearing during the administration of local anesthesia?

Accepted Answer

Barb on the needle

Answer

Passage through a cyst

Answer

Passage through a muscle

Answer

Passage through an area of infection

Question 8

What is the maximum dose of lignocaine without adrenaline that can be administered to a patient?

Accepted Answer

4 mg/kg body weight

Answer

5 mg/kg body weight

Answer

7 mg/kg body weight

Answer

9 mg/kg body weight

Question 9

All of the following statements about lignocaine are true EXCEPT?

Accepted Answer

It is given orally for the treatment of cardiac arrhythmias.

Answer

It blocks active sodium channels with more affinity than resting sodium channels.

Answer

It can cause cardiotoxicity.

Answer

Adrenaline increases the duration of action of lignocaine when used for infiltration anesthesia.

Question 10

Which of the following is a long-acting local anesthetic?

Accepted Answer

Bupivacaine

Answer

Procaine

Answer

Lidocaine

Answer

Etidocaine

Local Anesthetics — MCQs

Local Anesthetics — MCQs

On this page

Practice by Chapter

Want unlimited practice?